Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 605-614, July 2010

Synthesis, radiofluorination and first evaluation of [18F]fluorophenylsulfonyl- and [18F]fluorophenylsulfinyl-piperidines as serotonin 5-HT2A receptor antagonists for PET

Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, 52425 Jülich, Germany

Received 9 November 2009; received in revised form 4 February 2010; accepted 8 March 2010. published online 26 April 2010.

Abstract 

In psychiatric disorders, 5-HT2A receptors play an important role. In order to study these receptors in vivo by positron emission tomography (PET), there is an increasing interest for subtype selective and high affinity radioligands. Up to now, no optimal radiotracer is available. Thus, 1-(2,4-difluorophenethyl)-4-(4-fluorophenylsulfonyl)piperidine (9), possessing high affinity and sufficient subtype selectivity for 5-HT2A receptors, and 1-(2,4-difluorophenethyl)-4-(4-fluorophenylsulfinyl)piperidine (15) have been 18F-labelled by a nucleophilic one-step reaction. Both radiotracers could be prepared and isolated within 45 min, [18F]9 in a radiochemical yield (RCY) of 34.5±8% and [18F]15 of 9.5±2.5%. The Ki values of 9 and 15 at 5-HT2A receptors towards [3H]ketanserin were determined to be 1.9±0.6 and 198±8 nM, respectively. Autoradiography with [18F]9 and [18F]15 on rat brain sections showed a very high nonspecific binding of >80% for [18F]9 and 30% to 40% nonspecific binding for [18F]15; however, it is still too high in order to compensate for its lower affinity. Even though the affinity of 9 is more promising compared with 15, the high nonspecific binding of both radiofluorinated tracers in rat brain does not recommend those as an in vivo PET imaging agent for serotonin 5-HT2A receptors in humans.

Keywords: Radiofluorination, 5-HT2A antagonist, PET, Radioligand, Autoradiography

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(10)00060-0

doi:10.1016/j.nucmedbio.2010.03.003

Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 605-614, July 2010